the above chart is Acadia…that is a fine-looking breakout chart.
i would feel comfortable buying that stock, based on that chart.
So what is wrong with Neuren? Why is it being so pathetic lately?
Poor Acadia barely makes a profit after paying all the bills for selling its two drugs, while NEU just pockets 10-12% of the Daybue revenue before expenses plus milestones..
NEU is doing very nicely out of Daybue. Yet Acadia has the great looking chart, while a NEU's chart is sick.
makes no sense.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $14.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.23 | 3278 | 1 |
View Market Depth
| Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |